Efficacy of cevimeline vs. pilocarpine in the secretion of saliva: a pilot study

Spec Care Dentist. 2013 May-Jun;33(3):123-7. doi: 10.1111/scd.12010. Epub 2013 Jan 7.

Abstract

Objectives: To determine the efficacy and compare the side-effects of cevimeline and pilocarpine in the secretion of saliva in patients with xerostomia.

Methods: A randomized, cross-over, double blind study was designed. Fifteen patients with diagnosis of xerostomia were assigned to take either 5 mg of pilocarpine or 30 mg of cevimeline three times a day for four weeks. Salivary flow rates were measured during the initial baseline, first and second month appointments. Statistical analysis was carried out with ANOVA and post hoc t-tests.

Results: Twelve patients completed both medication treatments. Although both medications proved to increase salivary secretion, there was no significant difference between pilocarpine and cevimeline. Also, the perceived side-effects between the two medications were similar.

Conclusion: Both medications increased the secretion of saliva at the end of four weeks. However, there was a slightly higher increment in saliva with pilocarpine. However, the difference was not statistically significant.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Chi-Square Distribution
  • Cross-Over Studies
  • Double-Blind Method
  • Humans
  • Male
  • Muscarinic Agonists / adverse effects
  • Muscarinic Agonists / pharmacology*
  • Pilocarpine / adverse effects
  • Pilocarpine / pharmacology*
  • Pilot Projects
  • Quinuclidines / adverse effects
  • Quinuclidines / pharmacology*
  • Research Subjects / psychology
  • Salivation / drug effects*
  • Statistics, Nonparametric
  • Sweating
  • Tears / metabolism
  • Thiophenes / adverse effects
  • Thiophenes / pharmacology*
  • Xerostomia / drug therapy*

Substances

  • Muscarinic Agonists
  • Quinuclidines
  • Thiophenes
  • Pilocarpine
  • cevimeline